Institutional shares held 71.7 Million
168K calls
394K puts
Total value of holdings $39.3B
$92M calls
$216M puts
Market Cap $45.7B
83,253,696 Shares Out.
Institutional ownership 86.13%
# of Institutions 1,214


Latest Institutional Activity in IDXX

Top Purchases

Q1 2024
Neuberger Berman Group LLC Shares Held: 472K ($259M)
Q1 2024
Qube Research & Technologies LTD Shares Held: 299K ($164M)
Q1 2024
Black Rock Inc. Shares Held: 9.21M ($5.05B)
Q1 2024
Franklin Resources Inc Shares Held: 1.55M ($850M)
Q1 2024
Invesco Ltd. Shares Held: 1.47M ($806M)

Top Sells

Q1 2024
Select Equity Group, L.P. Shares Held: 118K ($64.5M)
Q1 2024
Umb Bank, N.A. Shares Held: 56.2K ($30.8M)
Q1 2024
Bamco Inc Shares Held: 2.1M ($1.15B)
Q1 2024
Manning & Napier Group, LLC Shares Held: 42.4K ($23.3M)
Q1 2024
Champlain Investment Partners, LLC Shares Held: 94.2K ($51.7M)

About IDXX

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.


Insider Transactions at IDXX

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
314K Shares
From 23 Insiders
Exercise of conversion of derivative security 165K shares
Grant, award, or other acquisition 1.44K shares
Bona fide gift 148K shares
Sell / Disposition
323K Shares
From 22 Insiders
Payment of exercise price or tax liability 5K shares
Open market or private sale 145K shares
Bona fide gift 172K shares
Exercise of conversion of derivative security 1.69K shares

Track Institutional and Insider Activities on IDXX

Follow IDEXX LABORATORIES INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IDXX shares.

Notify only if

Insider Trading

Get notified when an Idexx Laboratories Inc insider buys or sells IDXX shares.

Notify only if

News

Receive news related to IDEXX LABORATORIES INC

Track Activities on IDXX